Key result
IV Big endothelin-1 increases systemic vascular resistance ~65%, raising blood pressure and lowering cardiac output.
Why the study?
Does intravenous Big endothelin-1 infusion alter central and regional hemodynamics in healthy men?
Does intravenous Big endothelin-1 infusion alter central and regional hemodynamics in healthy men?
Circulating Big ET-1 elicits significant increases in mean arterial blood pressure and systemic vascular resistance, and decreases in heart rate and cardiac output in healthy humans.
Answers are grounded in this paper and cite their sources.
Big ET-1 infusion alters hemodynamics in healthy men; leaves open its role in hypertension or heart failure.
Big endothelin-1 (Big ET-1) was given intravenously to six healthy men to study uptakes and vascular effects. Blood samples were taken from systemic and pulmonary arterial and internal jugular and deep forearm venous catheters. Arterial Big ET-1-like immunoreactivity (Big ET-1-LI) increased from 5.43 +/- 0.60 to 756 +/- 27 pmol/l, and ET-1-LI increased from 4.67 +/- 0.08 to 6.67 +/- 0.52 pmol/l (P < 0.001). Skeletal muscle fractional extraction of Big ET-1-LI was 15 +/- 4%. ET-1-LI release did not increase in the studied vascular beds. Heart rate fell by 17% (P < 0.001), cardiac output fell by 26% (P < 0.001), and stroke volume fell by 11% (P < 0.05). Mean arterial blood pressure increased 18%, systemic vascular resistance increased 65%, and pulmonary vascular resistance increased 57% (P < 0.01-0.001). Pulmonary blood pressures, forearm blood flow, arterial pH, arterial PCO2, and systemic arterial-internal jugular venous O2 difference remained unchanged. No specific Big ET-1 receptors were found in human pulmonary membranes. The half-maximal inhibitory concentration for the receptor antagonist bosentan was 181 nM. In summary, circulating Big ET-1 elicits greater increases in mean arterial blood pressure and systemic vascular resistance and decreases in heart rate and cardiac output compared with an equimolar ET-1 infusion (26).
No takes yet. Share an insight, caveat, or question.
Ahlborg et al. (1996) studied Healthy (n=6). Big endothelin-1 (Big ET-1) vs. Equimolar ET-1 infusion was evaluated on Hemodynamic effects including heart rate, cardiac output, and blood pressure (p=<0.001). Intravenous infusion of Big endothelin-1 increased mean arterial blood pressure by 18% and systemic vascular resistance by 65%, while decreasing heart rate by 17% and cardiac output by 26%.
Synapse has enriched 10 related papers. Consider them for comparative context: